Print

Test score may predict which prostate cancer patients can safely skip combined therapy

https://www.facingourrisk.org/XRAY/skipping-prostate-cancer-combined-therapy
Full article: https://www.clinical-genitourinary-cancer.com/action/showPdf?pii=S1558-7673%2821%2900013-6

This study shows that a test score that estimates the aggressiveness of a person’s prostate cancer may also identify the best treatment for patients. (posted 7/9/21)

Este artículo está disponible en español.

Questions To Ask Your Health Care Provider

Open Clinical Trials

The following are studies enrolling people with early-stage prostate cancer.  

A number of other clinical trials for patients with early-stage prostate can be found here.

About FORCE

FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.